Clinical Trials Insight: 700027999
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2008
At a glance
- Drugs Tezampanel (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors TorreyPines Therapeutics Inc
- 24 Oct 2008 US FDA agreed that TorreyPines Therapeutics may initiate phase III program for tezampanel in acute migraine, according to TorreyPines Therapeutics media release.
- 29 Sep 2008 An end of phase II meeting with the US FDA conducted to discuss the phase III program for tezampanel in acute migraine headache.
- 31 Oct 2007 New trial record.